Evidence Building
How to Present Ongoing Research Grants as O-1A Evidence When the Award Period Spans Both the Petition and the Requested Employment Period
An active NIH or NSF grant is strong O-1A evidence — but timing complications arise when the grant spans the petition date and the requested employment period. This guide covers how to frame ongoing grants so adjudicators recognize their competitive significance.
Grants as O-1A evidence and the timing question
Active research grants occupy an unusual evidentiary position in O-1A petitions. Unlike a published paper, which is a static record of achievement, or a completed fellowship, which represents a historical award, an ongoing grant is simultaneously evidence of past competitive selection and a statement of continuing institutional confidence in the petitioner's research program. Federal research grants from the National Institutes of Health, the National Science Foundation, the Department of Energy, and other federal agencies are competitively awarded, and selection from among all eligible applicants in a grant program is direct evidence of recognition of the petitioner's work by a government agency — one of the explicit evidence categories in the O-1A awards criterion at 8 C.F.R. § 214.2(o)(3)(ii)(A)(1).
The timing complication arises when the grant's project period spans both the date of the O-1A petition and the requested period of authorized employment. USCIS may raise a concern in an RFE or denial that a grant that has not yet concluded is not a receipt of an award but rather an ongoing performance obligation, or that the petitioner's principal investigator status on the grant is not itself extraordinary because research grants are held by a broad range of faculty at research universities. Both concerns can be addressed effectively with proper framing in the cover letter and supporting expert declarations, but they arise frequently enough that petition preparers working with researcher clients should anticipate and address them proactively rather than waiting for an RFE.
A further complication arises when the petitioner is asking for O-1A status that extends beyond the grant's project period. USCIS adjudicators occasionally conflate the question of whether the petitioner is extraordinary with the question of whether they will have employment after the grant ends, misunderstanding the O-1A as requiring continuous grant funding rather than extraordinary ability and a bona fide job offer from a U.S. petitioner. O-1A status is not conditional on ongoing grant funding; the petitioner must demonstrate extraordinary ability and have a qualifying U.S. petitioner, but the period of requested status need not be coterminous with a grant's project period. The cover letter should address this distinction explicitly if the grant will end before the requested O-1A validity period.
The regulatory framework for grant awards
8 C.F.R. § 214.2(o)(3)(ii)(A)(1) lists as evidence for the O-1A awards criterion: receipt of nationally or internationally recognized prizes or awards for excellence in the field of endeavor. Federal research grants qualify as awards for excellence in the field when the cover letter explains that the grant was awarded through a competitive peer review process in which proposals were evaluated against national priorities and the petitioner's scientific merit, and that the applicant pool included researchers from across the country with comparable qualifications. The key framing is that the grant represents a formal determination by a scientific peer review panel — organized by a federal agency — that the petitioner's proposed research represents the best available science in the relevant program area.
NIH's standard grant mechanisms carry significantly different levels of prestige and competitive significance. The R35 Outstanding Investigator Award is explicitly described by NIH as recognizing investigators with a record of substantial achievement in their field; it provides seven-year continuous funding and is awarded to a small fraction of eligible investigators in covered research areas. An R35 is among the most probative grant evidence available for the awards criterion. An R01, which is more commonly held, is still significant evidence when the cover letter explains the success rate for the specific study section and funding period. These success rates are publicly reported by NIH in its Research Portfolio Online Reporting Tools database and should be cited by name and metric.
NSF grants have their own recognition hierarchy. The NSF CAREER Award — formally the Faculty Early Career Development Program — recognizes researchers who exemplify the role of teacher-scholar in the early stages of their career and carries a minimum five-year funding period. NSF program officers conduct a rigorous review process, and success rates for CAREER awards in competitive engineering and science divisions are typically well below twenty percent. The NSF Waterman Award, given annually to a small number of young researchers across all of NSF's disciplines, represents an even stronger recognition signal. When presenting NSF grants in the O-1A awards criterion, the petition should cite the specific funding division's success rate for the relevant program and the competitive applicant pool to contextualize the award's significance.
Grant evidence that persuades adjudicators
The most persuasive grant evidence packages include: a copy of the notice of award from the sponsoring agency, which formally documents the grant number, the award amount, the project period, and the petitioner's role as principal investigator; a one-to-two page lay summary of the funded research that explains what problem the research addresses and why it is scientifically important; peer review summary statements, which NIH releases after funding decisions and which show the specific scores assigned by the review panel; and NSF or NIH success rate data for the relevant grant mechanism and study section. Taken together, these documents allow the adjudicator to understand not only that the petitioner received a grant but that the grant was difficult to obtain and represented a competitive judgment about the petitioner's scientific standing.
Expert declarations that explain the competitive significance of the petitioner's grants — from senior researchers who have served on NIH study sections or NSF review panels — are among the most useful supplementary evidence in grant-heavy O-1A petitions. A declarant who can state, from personal experience reviewing grant applications, that the petitioner's funded proposal was evaluated against a large field of competing applications and received a score in the top percentile provides direct evidence of the grant's competitive significance. Declarations should be specific: a declarant who served on the relevant study section and personally reviewed applications competing for similar funding can speak with authority about what it means to be funded at the petitioner's score level.
Grant-adjacent evidence can strengthen the criterion substantially. Invitations to serve on NIH or NSF study sections as a reviewer — which require that the invitee be recognized by the agency as having sufficient expertise and standing to evaluate competitive proposals — demonstrate recognition by the granting agency and contribute to the judging criterion at 8 C.F.R. § 214.2(o)(3)(ii)(A)(4). Letters from NIH program officers or NSF program directors that express scientific enthusiasm for the petitioner's research program, where available, document government agency recognition in terms that explicitly invoke the recognition language of the O-1A standard. These program officer letters are not always obtainable, but when a program officer has communicated unusual interest in a petitioner's research program, that correspondence is valuable evidence.
Grant presentations that weaken petitions
USCIS adjudicators have become increasingly familiar with O-1A petitions from academic researchers, and experienced adjudicators are aware that research grants are a normal feature of university science careers rather than evidence of extraordinary ability in every case. The most commonly discounted grant evidence consists of subaward grants — where the petitioner is a co-investigator on a grant held by another institution or principal investigator — presented without explanation of the subaward structure. A subaward is not the same as a competitive grant award to the petitioner; the petitioner did not directly compete for the funding and was selected by the primary PI rather than by the granting agency. Subawards can contribute to critical role or original contributions evidence, but presenting them as award evidence without this structural explanation is a recurring error.
Grant supplements and administrative supplements — additional funding provided at a program officer's discretion to an existing grant, typically without competitive review — are also frequently discounted. While supplements demonstrate continued agency confidence in the research program, they do not represent a competitive peer review determination about the petitioner's extraordinary ability in the same way that a competitively reviewed initial award does. A petition that lists a series of supplements alongside the initial award as separate grant receipts can create an impression of grant accumulation that USCIS may scrutinize. The cover letter should clearly distinguish between competitively reviewed awards and administrative supplements, relying primarily on the competitively reviewed awards as awards criterion evidence.
Grants with low award amounts that were funded through mechanisms specifically designed for early-career or training researchers — including NIH F-series fellowships, NIH T32 training grants in which the petitioner was a trainee rather than a PI, or small foundation pilot grants — are recognized by experienced adjudicators as less probative of extraordinary ability than investigator-initiated research grants for which the petitioner independently proposed and won competitive funding. Training grants in particular — where the petitioner was selected into a funded training cohort rather than having won a competitive grant through independent proposal — should not be presented as awards evidence without a careful explanation of how the selection into the training program itself was competitive and merit-based.
Framing borderline grant evidence
The most challenging grant situations to frame effectively are those in which the petitioner has received a grant through a mechanism with a relatively high success rate — some NSF programs fund a substantial fraction of applications in a given year — or in which the petitioner is in a field where grant attainment is near-universal among tenured and tenure-track faculty. In these situations, the grant evidence alone is insufficient to demonstrate extraordinary ability, and the petition must supplement it with other criterion evidence that distinguishes the petitioner from the general population of funded researchers. The grant then serves less as primary awards criterion evidence and more as background documentation of recognized research standing.
For grants that are ongoing, the cover letter should explain the grant's continued significance explicitly rather than assuming its relevance is apparent from the award notice. An active R01 in its fourth year of a five-year project period represents not just a past award but a current scientific program that NIH has funded continuously through annual progress reviews; the continuity itself demonstrates ongoing agency confidence in the research direction. The argument that the grant is evidence of sustained recognition — rather than merely a historical award — can be made effectively if the cover letter explains the annual progress review process and notes that continued funding was not automatic but required demonstrated scientific progress.
When a grant's project period will end before the requested O-1A validity period, the petition should address this directly. USCIS sometimes issues RFEs questioning whether the petitioner will continue to have qualifying U.S. employment after the grant ends. The response requires a letter from the petitioner's institution confirming that the petitioner's position — faculty appointment, research scientist appointment, or equivalent — does not terminate with the grant, and explaining that the institution's employment relationship with the petitioner is independent of any specific grant's funding period. This institutional letter, combined with a clear cover letter explanation of how research faculty employment works at U.S. universities, addresses the timing concern proactively.
Auditing the grant evidence file before filing
Before submitting a grant-heavy O-1A petition, the preparer should conduct a structured review of the evidence package against three questions: first, does the evidence demonstrate that each grant cited was competitively awarded through a peer review process, rather than awarded administratively, and is that competitive selection process explained in the cover letter? Second, are the petitioner's grants meaningfully distinguished from those held by non-extraordinary researchers — either through the competitive significance of the specific grant mechanism, the success rate data, or the expert declarations explaining the competitive landscape? Third, if the grants overlap with the requested employment period, is the temporal relationship explained clearly and is the institutional employment letter submitted?
A useful pre-submission audit involves running the petition's grant evidence through the lens of a skeptical USCIS adjudicator: if an adjudicator's starting assumption is that research grants are a normal professional credential for faculty rather than evidence of extraordinary ability, does the petition's cover letter and expert evidence change that assumption? The answer should be clearly yes — the adjudicator should understand, after reading the cover letter and the declarant statements, that while grants are common among research faculty generally, grants at the petitioner's level of competitiveness and scale are held by a small fraction of active researchers. NSF or NIH success rate data, presented numerically, is essential to making this distinction concrete and auditor-verifiable.
The final audit should include a specificity check, ensuring that every evidentiary claim in the cover letter is grounded in a specific document submitted to the record. If the cover letter states that the petitioner's grants represent the top tier of competitive funding in their field, that claim should be supported by the success rate data, an expert declaration, or both. Claims that are made in the cover letter without corresponding documentary or declarant support are vulnerable to an RFE or denial notice asking for evidence of assertions made but not documented. The petition should be self-contained: everything asserted should be proven somewhere in the exhibit package.
What we typically gather for this kind of case
| Document | Where to source | Why it matters |
|---|---|---|
| Peer-reviewed publications | Web of Science / Scopus exports | Anchors original-contributions and authorship criteria |
| Citation analysis | Google Scholar profile + ESI top-1% data | Quantifies major significance in the field |
| Salary benchmark | BLS OEWS for SOC code + locality | Documents high-salary criterion at 90th-percentile or above |
| Critical-role letters | Direct supervisor + program director | Establishes role's importance, not just title |
What we see go wrong, again and again
- 01Treating extraordinary ability as a credentials checklist rather than a story of field-wide impact.
- 02Submitting bibliometric data (h-index, citation counts) without explaining what makes those numbers high relative to peers in the same sub-field.
- 03Relying on letters from collaborators or co-authors rather than independent experts who can speak to influence.
See if you qualify
Lando reviews your background against the O-1 visa criteria and tells you honestly where you stand. Free, no commitment.